Cisapride on harsh patent dispute.

Published: 2000-02-10 10:43:00

Updated: 2000-02-10 10:43:00

Janssen Korea's Prepulcid (cisapride), one of the top ethical drugs in the hospital market and a GI motility regulator, had earlier met an unprecedented challenge with many Cisapride generic products developed by domestic drug companies (Daewoong, Kyungdong and Hami), which provoked Janssen Korea...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK